• 318 Citations
20122022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

I have an interest in the development of clinical trials, as well as studying novel biomarkers that may be used as prognostic and predictive tools in the management of melanoma and other advanced skin cancers, as well as cancer of unknown primary.

Training Experience

2011Residency, Case Western Reserve University Hospital
2014Fellowship, New York University Medical Center

Education/Academic qualification

MD, Michigan State University

… → 2008

MS, Michigan State University

… → 2003

Keywords

  • Cancer of Unknown Primary
  • Clinical Research
  • Drug Discovery
  • Melanoma
  • Skin Cancer

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Precision Medicine Medicine & Life Sciences
CTLA-4 Antigen Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2013 2022

Research Output 2012 2019

  • 318 Citations
  • 14 Review article
  • 9 Article
  • 1 Chapter
  • 1 Short survey

Clinical characterization of colitis arising from anti-PD-1 based therapy

Wang, D. Y., Mooradian, M. J., Kim, D. W., Shah, N. J., Fenton, S. E., Conry, R. M., Mehta, R., Silk, A. W., Zhou, A., Compton, M. L., Al-Rohil, R. N., Lee, S., Voorhees, A. L., Ha, L., McKee, S., Norrell, J. T., Mehnert, J., Puzanov, I., Sosman, J. A., Chandra, S. & 5 othersGibney, G. T., Rapisuwon, S., Eroglu, Z., Sullivan, R. & Johnson, D. B., Jan 2 2019, In : OncoImmunology. 8, 1, e1524695.

Research output: Contribution to journalArticle

Colitis
Steroids
Therapeutics
Prednisone
Melanoma
1 Citations (Scopus)
Melanoma
Vaccination
Clinical Trials
CD274 Antigen
Neoplasms
14 Citations (Scopus)
Non-Small Cell Lung Carcinoma
Immunotherapy
Melanoma
Clinical Trials
CTLA-4 Antigen
14 Citations (Scopus)

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis

Wang, D. Y., Salem, J. E., Cohen, J. V., Chandra, S., Menzer, C., Ye, F., Zhao, S., Das, S., Beckermann, K. E., Ha, L., Rathmell, W. K., Ancell, K. K., Balko, J. M., Bowman, C., Davis, E. J., Chism, D. D., Horn, L., Long, G. V., Carlino, M. S., Lebrun-Vignes, B. & 7 othersEroglu, Z., Hassel, J. C., Menzies, A. M., Sosman, J. A., Sullivan, R. J., Moslehi, J. J. & Johnson, D. B., Dec 1 2018, In : JAMA oncology. 4, 12, p. 1721-1728 8 p.

Research output: Contribution to journalArticle

CTLA-4 Antigen
Poisons
Meta-Analysis
Colitis
Pharmacovigilance
2 Citations (Scopus)

Immune Checkpoint Inhibitor Toxicity in 2018

Johnson, D. B., Chandra, S. & Sosman, J. A., Oct 23 2018, In : JAMA - Journal of the American Medical Association. 320, 16, p. 1702-1703 2 p.

Research output: Contribution to journalShort survey